Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 15, 2021
Quantifying the heterogeneity of cognitive functioning in Alzheimer's disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
Stephen Z Levine, Yair Goldberg, Kazufumi Yoshida, et al.
Journal of Psychiatric Research
|
February 6, 2022
Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil
Stephen Z Levine, Yair Goldberg, Kazufumi Yoshida, et al.
Schizophrenia Bulletin
|
April 5, 2015
Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method
Stefan Leucht, Myrto Samara, Stephan Heres, et al.
Vaccines
|
August 26, 2022
COVID-19 Vaccination and Mental Health Outcomes among Greek Adults in 2021: Preliminary Evidence
Kyriakos Souliotis, Lily E Peppou, Theodoros V Giannouchos, et al.
Journal of Gastroenterology and Hepatology
|
August 19, 2020
Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease
Andreas Vadarlis, Christina Antza, Dimitra Rafailia Bakaloudi, et al.
JAMA Psychiatry
|
November 6, 2014
Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies
Toshi A Furukawa, Stephen Z Levine, Shiro Tanaka, et al.
Frontiers in Psychiatry
|
May 13, 2025
Treatment-resistant or difficult-to-treat depression: a consensus on the pharmacotherapy challenges and considerations for the health care system in Greece
Kyriakos Souliotis, Christina Golna, Myrto Samara, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 1, 2023
A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia
Shimeng Dong, Johannes Schneider-Thoma, Irene Bighelli, et al.
Evidence-Based Mental Health
|
October 7, 2020
Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil
Stephen Z Levine, Kazufumi Yoshida, Yair Goldberg, et al.
Statistics in Medicine
|
January 14, 2017
Combining randomized and non-randomized evidence in network meta-analysis
Orestis Efthimiou, Dimitris Mavridis, Thomas P A Debray, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 15, 2021
Quantifying the heterogeneity of cognitive functioning in Alzheimer's disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
Stephen Z Levine, Yair Goldberg, Kazufumi Yoshida, et al.
Journal of Psychiatric Research
|
February 6, 2022
Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil
Stephen Z Levine, Yair Goldberg, Kazufumi Yoshida, et al.
Schizophrenia Bulletin
|
April 5, 2015
Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method
Stefan Leucht, Myrto Samara, Stephan Heres, et al.
Vaccines
|
August 26, 2022
COVID-19 Vaccination and Mental Health Outcomes among Greek Adults in 2021: Preliminary Evidence
Kyriakos Souliotis, Lily E Peppou, Theodoros V Giannouchos, et al.
Journal of Gastroenterology and Hepatology
|
August 19, 2020
Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease
Andreas Vadarlis, Christina Antza, Dimitra Rafailia Bakaloudi, et al.
JAMA Psychiatry
|
November 6, 2014
Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies
Toshi A Furukawa, Stephen Z Levine, Shiro Tanaka, et al.
Frontiers in Psychiatry
|
May 13, 2025
Treatment-resistant or difficult-to-treat depression: a consensus on the pharmacotherapy challenges and considerations for the health care system in Greece
Kyriakos Souliotis, Christina Golna, Myrto Samara, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 1, 2023
A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia
Shimeng Dong, Johannes Schneider-Thoma, Irene Bighelli, et al.
Evidence-Based Mental Health
|
October 7, 2020
Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil
Stephen Z Levine, Kazufumi Yoshida, Yair Goldberg, et al.
Statistics in Medicine
|
January 14, 2017
Combining randomized and non-randomized evidence in network meta-analysis
Orestis Efthimiou, Dimitris Mavridis, Thomas P A Debray, et al.
Page
of 6